Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Deloitte Life Sciences Consultancy Competitors: What Sets EvoLV Apart

Apr 11, 2026

Understanding the Competitive Landscape

In the rapidly evolving field of life sciences consultancy, firms like Deloitte have established themselves as formidable players. However, as the industry grows, new competitors are emerging with innovative approaches and specialized expertise. Among them, EvoLV is making a significant impact. Understanding what sets EvoLV apart from its competitors can provide valuable insights into the future of life sciences consultancy.

life sciences consultancy

Specialized Expertise in Life Sciences

While many consulting firms offer a broad range of services across various industries, EvoLV focuses specifically on the life sciences sector. This specialization allows them to develop a deep understanding of the unique challenges and opportunities within the field. EvoLV's consultants are experts in areas such as biotechnology, pharmaceuticals, and healthcare, providing clients with highly tailored solutions.

This industry-specific focus enables EvoLV to stay ahead of trends and anticipate the needs of their clients more effectively than competitors who may spread their resources across multiple sectors.

Innovative Approaches to Problem Solving

EvoLV stands out for its commitment to innovation. The firm invests heavily in research and development to create cutting-edge solutions that address the complex issues faced by life sciences companies. By leveraging technology and data analytics, EvoLV offers insights that drive strategic decision-making and foster growth.

innovation in consultancy

Their innovative mindset is supported by a culture that encourages creative thinking and collaboration, ensuring that clients benefit from the latest advancements in the field.

Client-Centric Philosophy

One of EvoLV's core strengths is its client-centric approach. The firm prioritizes building strong relationships with clients, understanding their unique needs, and delivering customized strategies. This personalized service sets EvoLV apart from larger competitors who may rely on a more standardized approach.

Clients appreciate EvoLV's dedication to transparency, communication, and partnership, which fosters trust and long-term collaboration.

client meeting

Agility and Flexibility

In an industry where change is constant, EvoLV's agility and flexibility provide a significant advantage. Unlike larger, more rigid firms, EvoLV can quickly adapt to new developments and client requirements. This responsiveness ensures that clients receive timely and relevant solutions that align with their evolving objectives.

The ability to pivot and innovate rapidly is crucial in the life sciences sector, where regulatory changes and technological advancements are the norm.

A Focus on Sustainability

EvoLV is committed to sustainability, understanding its importance not only for the environment but also for the long-term success of their clients. The firm integrates sustainable practices into their consulting processes, helping clients reduce their environmental footprint while enhancing operational efficiency.

This commitment to sustainability resonates with clients who are increasingly prioritizing environmental responsibility in their business strategies.

Conclusion: The EvoLV Advantage

In the competitive landscape of life sciences consultancy, EvoLV distinguishes itself through specialized expertise, innovative solutions, a client-centric approach, and a commitment to sustainability. These attributes position EvoLV as a leader in the field, offering clients a unique combination of deep industry knowledge and forward-thinking strategies.

As the life sciences sector continues to evolve, EvoLV's dedication to excellence and innovation ensures that they will remain at the forefront, helping clients navigate the complexities of the industry with confidence.